CN108872606A - 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 - Google Patents
一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 Download PDFInfo
- Publication number
- CN108872606A CN108872606A CN201810922651.4A CN201810922651A CN108872606A CN 108872606 A CN108872606 A CN 108872606A CN 201810922651 A CN201810922651 A CN 201810922651A CN 108872606 A CN108872606 A CN 108872606A
- Authority
- CN
- China
- Prior art keywords
- reagent
- hoptoglobin
- buffer
- sensitive
- highly stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 32
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 83
- 239000004816 latex Substances 0.000 claims abstract description 28
- 229920000126 latex Polymers 0.000 claims abstract description 28
- 239000000872 buffer Substances 0.000 claims abstract description 25
- 239000002253 acid Substances 0.000 claims abstract description 23
- 150000002148 esters Chemical class 0.000 claims abstract description 22
- 239000002245 particle Substances 0.000 claims abstract description 21
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 20
- 239000000845 maltitol Substances 0.000 claims abstract description 20
- 229940035436 maltitol Drugs 0.000 claims abstract description 20
- 235000010449 maltitol Nutrition 0.000 claims abstract description 20
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims abstract description 20
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims abstract description 18
- 239000003755 preservative agent Substances 0.000 claims abstract description 18
- 230000002335 preservative effect Effects 0.000 claims abstract description 18
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- XNPKNHHFCKSMRV-UHFFFAOYSA-N 4-(cyclohexylamino)butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCNC1CCCCC1 XNPKNHHFCKSMRV-UHFFFAOYSA-N 0.000 claims description 29
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- 230000021523 carboxylation Effects 0.000 claims description 2
- 238000006473 carboxylation reaction Methods 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000001384 succinic acid Substances 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 abstract description 17
- 230000035945 sensitivity Effects 0.000 abstract description 11
- 230000003053 immunization Effects 0.000 abstract description 2
- 238000002649 immunization Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 21
- 238000003908 quality control method Methods 0.000 description 11
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 10
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 10
- 102000014702 Haptoglobin Human genes 0.000 description 6
- 108050005077 Haptoglobin Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 238000004879 turbidimetry Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 102000018146 globin Human genes 0.000 description 3
- 108060003196 globin Proteins 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810922651.4A CN108872606B (zh) | 2018-08-14 | 2018-08-14 | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810922651.4A CN108872606B (zh) | 2018-08-14 | 2018-08-14 | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108872606A true CN108872606A (zh) | 2018-11-23 |
CN108872606B CN108872606B (zh) | 2020-12-22 |
Family
ID=64319044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810922651.4A Active CN108872606B (zh) | 2018-08-14 | 2018-08-14 | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108872606B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109725160A (zh) * | 2018-12-30 | 2019-05-07 | 山东博科生物产业有限公司 | 一种降钙素原(pct)检测试剂盒 |
CN111381040A (zh) * | 2018-12-27 | 2020-07-07 | 山东博科生物产业有限公司 | 一种性能高效的检测结合珠蛋白检测试剂 |
CN113433317A (zh) * | 2021-06-23 | 2021-09-24 | 湖北民族大学附属民大医院 | 一种基质金属蛋白酶-3测定试剂盒及其制备方法 |
CN117368466A (zh) * | 2023-12-08 | 2024-01-09 | 安徽惠邦生物工程有限公司 | 用生化分析仪测定尿结合珠蛋白的试剂盒及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101305093A (zh) * | 2005-11-11 | 2008-11-12 | 东洋纺织株式会社 | 用于稳定生物分子的方法及组合物 |
CN102115737A (zh) * | 2009-12-31 | 2011-07-06 | 深圳迈瑞生物医疗电子股份有限公司 | 稳定碱性磷酸酶或其标记物的试剂和方法 |
CN104215770A (zh) * | 2014-08-14 | 2014-12-17 | 上海睿康生物科技有限公司 | 一种基于双粒子的视黄醇结合蛋白检测试剂盒 |
CN104535756A (zh) * | 2008-07-04 | 2015-04-22 | 积水医疗株式会社 | 免疫学测定的灵敏度增强方法或避免血红蛋白影响的方法 |
CN105334211A (zh) * | 2015-10-20 | 2016-02-17 | 北京中生金域诊断技术股份有限公司 | 一种同时检测尿液中钠和肌酐的试剂盒 |
CN106053839A (zh) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | 一种测定结合珠蛋白的试剂盒及其制备方法 |
-
2018
- 2018-08-14 CN CN201810922651.4A patent/CN108872606B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101305093A (zh) * | 2005-11-11 | 2008-11-12 | 东洋纺织株式会社 | 用于稳定生物分子的方法及组合物 |
CN104535756A (zh) * | 2008-07-04 | 2015-04-22 | 积水医疗株式会社 | 免疫学测定的灵敏度增强方法或避免血红蛋白影响的方法 |
CN102115737A (zh) * | 2009-12-31 | 2011-07-06 | 深圳迈瑞生物医疗电子股份有限公司 | 稳定碱性磷酸酶或其标记物的试剂和方法 |
CN104215770A (zh) * | 2014-08-14 | 2014-12-17 | 上海睿康生物科技有限公司 | 一种基于双粒子的视黄醇结合蛋白检测试剂盒 |
CN105334211A (zh) * | 2015-10-20 | 2016-02-17 | 北京中生金域诊断技术股份有限公司 | 一种同时检测尿液中钠和肌酐的试剂盒 |
CN106053839A (zh) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | 一种测定结合珠蛋白的试剂盒及其制备方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111381040A (zh) * | 2018-12-27 | 2020-07-07 | 山东博科生物产业有限公司 | 一种性能高效的检测结合珠蛋白检测试剂 |
CN109725160A (zh) * | 2018-12-30 | 2019-05-07 | 山东博科生物产业有限公司 | 一种降钙素原(pct)检测试剂盒 |
CN113433317A (zh) * | 2021-06-23 | 2021-09-24 | 湖北民族大学附属民大医院 | 一种基质金属蛋白酶-3测定试剂盒及其制备方法 |
CN113433317B (zh) * | 2021-06-23 | 2024-02-02 | 湖北民族大学附属民大医院 | 一种基质金属蛋白酶-3测定试剂盒及其制备方法 |
CN117368466A (zh) * | 2023-12-08 | 2024-01-09 | 安徽惠邦生物工程有限公司 | 用生化分析仪测定尿结合珠蛋白的试剂盒及其制备方法 |
CN117368466B (zh) * | 2023-12-08 | 2024-03-12 | 安徽惠邦生物工程有限公司 | 用生化分析仪测定尿结合珠蛋白的试剂盒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108872606B (zh) | 2020-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108872606A (zh) | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 | |
CN102759631B (zh) | 一种定量检测降钙素原pct的胶乳增强免疫比浊试剂盒 | |
CN101377492B (zh) | 胱抑素c测定试剂盒 | |
CN102621332B (zh) | 基于胶乳粒子包被视黄醇结合蛋白检测试剂盒 | |
CN112526134A (zh) | 一种壳多糖酶3样蛋白1测定试剂盒 | |
CN101377506A (zh) | 磷脂酰肌醇蛋白聚糖-3化学发光免疫分析测定试剂盒及其制备方法 | |
CN111239421A (zh) | 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法 | |
CN102636653A (zh) | 复合胶乳粒子包被胱抑素c检测试剂盒 | |
CN106053839A (zh) | 一种测定结合珠蛋白的试剂盒及其制备方法 | |
CN101699287A (zh) | 匀相溶胶颗粒型胱抑素c测定试剂盒及其制备方法 | |
CN106932594A (zh) | 一种优选胱抑素c检测试剂盒及其制备方法 | |
CN112014572A (zh) | 一种用于检测kl-6的乳胶颗粒制备方法及其应用 | |
CN108872607B (zh) | 一种α2-巨球蛋白(α2-MG)检测试剂盒 | |
US8691515B2 (en) | Methods for early detection of blood disorders | |
CN101320041A (zh) | 一种快速定量检测c-反应蛋白的胶体金法及其应用 | |
CN107228940A (zh) | 一种胱抑素c的检测试剂及方法 | |
CN112763725B (zh) | 一种胶乳比浊法测定c反蛋白检测试剂的制备及应用 | |
CN106443004A (zh) | 一种快速定量同时检测cTnI、H‑FABP的时间分辨荧光免疫层析试剂及制备方法 | |
CN106324234B (zh) | 修饰的n-乙酰神经氨酸醛缩酶及其制备方法和应用 | |
EP3923806A1 (en) | Calibrators and controls for the determination of percent glycated hemoglobin in a patient's liquid test sample | |
CN114295840B (zh) | 一种高灵敏度定量测定脂联素的试剂盒及其制备方法 | |
CN106501526A (zh) | 一种组合定向剂优化胶乳偶联抗体检测前白蛋白(pa)的试剂盒 | |
CN109164259A (zh) | 一种灵敏度高的结合珠蛋白检测试剂盒 | |
CN105510572A (zh) | 一种甘氨酰脯氨酸二肽氨基肽酶检测试剂盒 | |
CN109254145A (zh) | 用于改善新鲜血清和第三方质控之间基质效应的稀释液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A highly stable and sensitive binding Globin (HP) detection kit Effective date of registration: 20230628 Granted publication date: 20201222 Pledgee: Bank of Communications Ltd. Shandong branch Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980045843 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20201222 Pledgee: Bank of Communications Ltd. Shandong branch Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980045843 |